GalliPro® receives final approval in Europe
10-05-10
Chr. Hansen expects to get the final marketing authorization in Europe for its probiotic feed ingredient for poultry within the next few months
A vote among EU member states in the Standing Committee of Animal Nutrition on April 28, 2010 resulted in the approval to use Chr. Hansen’s active feed ingredient, GalliPro®, in industrial feed for poultry containing coccidiostats (antiprotozoal agents that act upon Coccidia parasites).
Based on this member state decision - following a positive opinion from the European Food Safety Agency (EFSA) - Chr. Hansen expects publication in the Official Journal and thus final marketing authorization within the next few months.
Good experiences in Brazil
"We are pleased about the prospects of bringing this product to the European market. We have had the product on the market in Brazil, which is among the top poultry producing market in the world for several years and have built a strong customer base for the product there in collaboration with our local partner.
Our sales development and positive experiences here confirm and strengthen our belief in the concept,” says Inge Knap, Director, Development and Application, Animal Health and Nutrition, Chr. Hansen Europe.
Increases growth performance for poultry
”The approval of GalliPro® for commercialization in the European Union market will be an important step in building our poultry franchise in Europe. We look forward to making the product available to commercial broiler producers.
Data shows how GalliPro® consistently increases growth performance, improves feed conversion and also how it contributes to lowered mortality, reduced Salmonella and improved litter quality.
We therefore look forward to commercializing this product in collaboration with our European partners and aim at GalliPro® becoming a standard part of commercial broiler diets,” says Lars-Inge Olsson, Sales Manager, Animal Health and Nutrition, Chr. Hansen Europe.
Naturally occurring Bacillus spores
GalliPro® is a probiotic that contains selected, safe, naturally-occurring Bacillus spores. GalliPro® has proven beneficial effects, which are backed by strong data generated in scientific as well as on-farm trials. GalliPro® brings consistent and well documented results and can be used in pelletized feed as the strains are heat-resistant.
“We are continuously working on strengthening the data package supporting GalliPro® and will continue to develop our knowledge and push the awareness of probiotic products to the benefit of all customers,” Inge Knap concludes.
For further information please contact:
Phone: +45 45 74 76 36 Mobile: +45 2074 2840
E-mail: dkhre@chr-hansen.com
About Chr. Hansen
Chr. Hansen is a global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries. All solutions are based on strong research and development competencies and significant technology investments. Revenue in FY2008/09 was EUR 511 million. The company enjoys market leadership in all its divisions: Cultures & Enzymes, Health & Nutrition and Colors & Blends. There are more than 2,200 dedicated employees in over 30 countries.

